1
|
Rodríguez-Tanta LY, Garavito Farro H, Freitas Leal L, Salas M, Elseviers MM, Lopes LC. Drug utilization research in Peru: Is real-world data available? Front Pharmacol 2023; 13:1047946. [PMID: 36733379 PMCID: PMC9888663 DOI: 10.3389/fphar.2022.1047946] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2022] [Accepted: 12/28/2022] [Indexed: 01/18/2023] Open
Abstract
Background: Drug utilization research (DUR) is used to provide evidence-based data to inform policies and make decisions. The aim of this study was to map and describe available data sources for drug utilization research in Peru. Methods: We performed a search of data sources providing information on medication use on the website of governmental organizations. We also conducted a literature review using PubMed, LILACs, and BVS. Independently, researchers screened eligible data sources. Data characterization included accessibility, coverage data provider, type of data sources, and setting. We performed a descriptive analysis. Results: We identified seven data sources, CENAFyT, ICI, IDI (SISMED), and ENSUSALUD from MINSA, and CRI-ESSALUD, SGSS/ESSI, and ENSSA from ESSALUD. These presented information on adverse drug reactions (n = 2), drug consumption, and distribution (n = 2), prescription and drug dispensing (n = 1), and surveys addressed to medication users (n = 2). ENSUSALUD was the only data source publicly available. VIGIFLOW and ENSUSALUD have a national granularity from the public and private sectors. The setting of the data sources was both hospital and ambulatory care. Two data sources have individual-level data on adverse drug reactions and one on prescriptions. Four studies on drug utilization research in Peru were derived from ENSUSALUD. Conclusion: In Peru, few data sources are available for drug utilization research. There is an increased need to monitor medications for decision-making purposes. Local and international initiatives and partnerships of the government with academic institutions and the private sector might be a good strategy to increase the transparency of health data and for supporting decision-making using drug utilization research.
Collapse
Affiliation(s)
- L. Yesenia Rodríguez-Tanta
- Institute for the Evaluation of Health Technologies and Research, Social Security of Health, Lima, Peru,*Correspondence: L. Yesenia Rodríguez-Tanta, ; Luciane Cruz Lopes,
| | | | - Lisiane Freitas Leal
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
| | - Maribel Salas
- Daiichi Sankyo (United States), Parsippany, NJ, United States,Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
| | | | - Luciane Cruz Lopes
- Pharmaceutical Science Graduate Course, University of Sorocaba, São Paulo, Brazil,*Correspondence: L. Yesenia Rodríguez-Tanta, ; Luciane Cruz Lopes,
| |
Collapse
|
2
|
Kagoya HR, Rennie TW, Kibuule D, Mitonga HK. Alignment of standard treatment guidelines with medicine use indicators in a limited‐resource setting: findings and implications. JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH 2020. [DOI: 10.1111/jphs.12351] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Harriet Rachel Kagoya
- School of Public Health Faculty of Health Sciences University of Namibia Windhoek Namibia
| | | | - Dan Kibuule
- School of Pharmacy Faculty of Health Sciences University of Namibia Windhoek Namibia
| | | |
Collapse
|
3
|
Ogunleye OO, Fadare JO, Eriksen J, Oaiya O, Massele A, Truter I, Taylor SJE, Godman B, Gustafsson LL. Reported needs of information resources, research tools, connectivity and infrastructure among African Pharmacological Scientists to improve future patient care and health. Expert Rev Clin Pharmacol 2019; 12:481-489. [PMID: 30961406 DOI: 10.1080/17512433.2019.1605903] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
INTRODUCTION The potentials of Africa for growth and economic transformation through science remains challenging because of existing gaps in knowledge and infrastructure. The Africa Pharmacological Science Gateway project and the Medicines Utilization Research in Africa Group seek to meet the research needs of African pharmacologists. This study aimed at identifying priority needs that might be met by access to information and tools through e-infrastructure. METHODS A web-based cross-sectional study among 472 members of pharmacological societies in Africa to obtain information on their research interests and skills, available resources, needs, and knowledge gaps. Descriptive analyses were done. RESULTS A total of 118 responses from 13 countries were received, mostly from Nigeria (48.3%) and South Africa (21.3%). Respondents had wide ranges of research interests predominantly in drug utilization research. The desired resources included drug utilization research training and tools, pharmacokinetics and pharmacometrics modeling training and tools, drug-drug interaction and medicine prices resources, statistical analysis resources, access to journals, training in specific laboratory techniques, equipment and funding for research-related activities. CONCLUSIONS Key areas of needs not currently provided by the African Pharmacological Science Gateway e-infrastructure were identified to guide the further provision of resources on the e-infrastructure and potentially enhance research capacity within the continent.
Collapse
Affiliation(s)
- Olayinka O Ogunleye
- a Department of Pharmacology, Therapeutics and Toxicology , Lagos State University College of Medicine , Lagos , Nigeria.,b Department of Medicine , Lagos State University Teaching Hospital , Lagos , Nigeria
| | - Joseph O Fadare
- c Department of Pharmacology and Therapeutics , College of Medicine, Ekiti State University , Ado-Ekiti , Nigeria
| | - Jaran Eriksen
- d Division of Clinical Pharmacology, Department of Laboratory Medicine , Karolinska Institutet, Karolinska University Hospital , Stockholm , Sweden.,e Department of Public Health Sciences , Karolinska Institutet , Stockholm , Sweden
| | - Omo Oaiya
- f West and Central Africa Research and Education Network , Accra , Ghana
| | - Amos Massele
- g Department of Biomedical Sciences, Faculty of Medicine , University of Botswana , Gaborone , Botswana
| | - Ilse Truter
- h Drug Utilization Research Unit (DURU), Department of Pharmacy , Nelson Mandela Metropolitan University , Port Elizabeth , South Africa
| | - Simon J E Taylor
- i Department of Computer Science , Brunel University , London , U.K
| | - Brian Godman
- d Division of Clinical Pharmacology, Department of Laboratory Medicine , Karolinska Institutet, Karolinska University Hospital , Stockholm , Sweden.,j Strathclyde Institute of Pharmacy and Biomedical Sciences , University of Strathclyde , Glasgow , U.K .,k Department of Health Economics , Liverpool Management School, Liverpool University , Liverpool , U.K .,l School of Pharmacy , Sefako Makgatho Health Sciences University , Pretoria , South Africa
| | - Lars L Gustafsson
- d Division of Clinical Pharmacology, Department of Laboratory Medicine , Karolinska Institutet, Karolinska University Hospital , Stockholm , Sweden
| |
Collapse
|
4
|
Tiroyakgosi C, Matome M, Summers E, Mashalla Y, Paramadhas BA, Souda S, Malone B, Sinkala F, Kgatlwane J, Godman B, Mmopi K, Massele A. Ongoing initiatives to improve the use of antibiotics in Botswana: University of Botswana symposium meeting report. Expert Rev Anti Infect Ther 2018; 16:381-384. [DOI: 10.1080/14787210.2018.1467756] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Affiliation(s)
- Celda Tiroyakgosi
- Ministry of Health and Wellness, Nelson Mandela Drive, Gaborone, Botswana
| | | | | | - Yohana Mashalla
- Department of Biomedical Sciences, Faculty of Medicine, University of Botswana, Gaborone, Botswana
| | - Bene Anand Paramadhas
- Department of Pharmacy, Nyangabgwe Hospital, Francistown, Botswana
- College of Graduate Studies, University of South Africa, Pretoria, South Africa
| | - Sajini Souda
- Department of Pathology, University of Botswana, Gaborone, Botswana
| | | | - Fatima Sinkala
- Department of Pharmacy, Letsholathebe II memorial hospital, Maun, Botswana
| | - Joyce Kgatlwane
- School of Pharmacy, University of Botswana, Gaborone, Botswana
| | - Brian Godman
- Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Huddinge, Sweden
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
- Health Economics Centre, Liverpool University Management School, Liverpool, UK
| | - Keneilwe Mmopi
- Department of Biomedical Sciences, Faculty of Medicine, University of Botswana, Gaborone, Botswana
| | - Amos Massele
- Department of Biomedical Sciences, Faculty of Medicine, University of Botswana, Gaborone, Botswana
| |
Collapse
|
5
|
Abstract
INTRODUCTION:The socioeconomic burden of diseases is increasing in Africa. For instance in 2011, 70 percent of the world's human immunodeficiency virus (HIV) population resided in sub-Sahara Africa. There are also growing rates of Antimicrobial Resistance (AMR), which necessitates newer more expensive antibiotics adding to costs. There is also a growing burden of non-communicable diseases (NCDs), three out of four patients with hypertension currently live in low and middle income countries (LMICs), with prevalence rates up to 30 to 45 percent among adults in Africa. Alongside this, up to 70 percent of total healthcare expenditure is spent on medicines in LMICs; much of this out-of-pocket. Consequently, there is an urgent need to strengthen collaborative research to improve medicine use.METHODS:Summary of groups working together in Africa including the Medicines Utilisation Research in Africa (MURIA) group.RESULTS:African Strategies for Health identifies and advocates best practices, as well as works with others to develop sustainable solutions. Pharmacology for Africa (PharfA) organises and promotes pharmacology on the African continent, including research in clinical pharmacology, alongside the International Union of Basic and Clinical Pharmacology (IUPHAR) sub-division. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Africa co-ordinates activities from the different African country chapters. The South African Health Technology Assessment Society (SAHTAS) is a scientific and professional society for all those who produce, use, or encounter Health Technology Assessment (HTA) in Southern Africa, and the World Health Organization (WHO) International and Regional groups are improving antibiotic drug utilization capabilities in Africa. The MURIA group was established in 2015 (1). Ongoing collaborative research includes (i) initiatives to optimize antibiotic use; (ii) methods to enhance adherence to anti-infective prescribing guidance, (iii) approaches to improve adherence to HIV and NCDs; (iv) researching current anti-hypertensive utilization patterns and knowledge; (v) approaches to enhance Drugs and Therapeutic Committees (DTC) activities, and (vi) strengthening medicine utilization capabilities (2,3). These activities have already strengthened research ties across Africa.CONCLUSIONS:A number of groups are already working across Africa to enhance appropriate medicine use, and should continue. Ongoing MURIA activities include antibiotic point-prevalence studies, ongoing research into infectious diseases, NCDs and DTCs including adherence as well as the third workshop and symposium in Namibia in 2017.
Collapse
|
6
|
Massele A, Burger J, Kalemeera F, Jande M, Didimalang T, Kalungia AC, Matshotyana K, Law M, Malone B, Ogunleye O, Oluka M, Paramadhas BD, Rwegerera G, Zinyowera S, Godman B. Outcome of the second Medicines Utilisation Research in Africa Group meeting to promote sustainable and appropriate medicine use in Africa. Expert Rev Pharmacoecon Outcomes Res 2016; 17:149-152. [DOI: 10.1080/14737167.2017.1256775] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Amos Massele
- Department of Clinical Pharmacology, School of Medicine, University of Botswana, Gaborone, Botswana
| | - Johanita Burger
- Medicine Usage in South Africa (MUSA), Faculty of Health Sciences, School of Pharmacy, North-West University, Potchefstroom, South Africa
| | | | - Mary Jande
- School of Pharmacy, Catholic University of Health and Allied Sciences, Mwanza, United Republic of Tanzania
| | | | | | - Kidwell Matshotyana
- Management Sciences for Health Swaziland-Mbabane, Pharmaceuticals and Health Technology Group, Mbabane, Swaziland
| | - Michael Law
- University of British Columbia, Vancouver, Canada
| | | | - Olayinka Ogunleye
- Department of Medicine, Lagos State University Teaching Hospital - Clinical Pharmacology Unit, Ikeja, Nigeria
| | - Margaret Oluka
- Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, Nairobi, Kenya
| | | | - Godfrey Rwegerera
- Department of Internal Medicine, University of Botswana, Gaborone, Botswana
| | | | - Brian Godman
- Division of Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
| |
Collapse
|
7
|
Massele A, Tiroyakgosi C, Matome M, Desta A, Muller A, Paramadhas BDA, Malone B, Kurusa G, Didimalang T, Moyo M, Godman B. Research activities to improve the utilization of antibiotics in Africa. Expert Rev Pharmacoecon Outcomes Res 2016; 17:1-4. [DOI: 10.1586/14737167.2016.1164040] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Amos Massele
- Department of Clinical Pharmacology, School of Medicine, University of Botswana, Gaborone, Botswana
| | | | | | - Abayneh Desta
- WHO Regional Office for Africa, Brazzaville, Republic of Congo
| | | | - Bene D. Anand Paramadhas
- Department of Pharmacy, Nyangabgwe Hospital, Francistown, Botswana
- University of South Africa, Pretoria, South Africa
| | | | | | | | - Mosana Moyo
- Gaborone Private Hospital, Gaborone, Botswana
| | - Brian Godman
- Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
| |
Collapse
|
8
|
Massele A, Burger J, Katende-Kyenda NL, Kalemeera F, Kenaope T, Kibuule D, Mbachu O, Mubita M, Oluka M, Olusanya A, Paramadhas BDA, van Zyl P, Godman B. Outcome of the first Medicines Utilization Research in Africa group meeting to promote sustainable and rational medicine use in Africa. Expert Rev Pharmacoecon Outcomes Res 2015; 15:885-8. [DOI: 10.1586/14737167.2015.1088386] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|